Dipeptidyl peptidase-4 inhibitors and preservation of pancreatic islet-cell function: a critical appraisal of the evidence

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)101-111
JournalDiabetes, Obesity and Metabolism
Volume14
Issue number2
DOIs
Publication statusPublished - 2012

Cite this

@article{4c9978dc980944e7bd98897244718dac,
title = "Dipeptidyl peptidase-4 inhibitors and preservation of pancreatic islet-cell function: a critical appraisal of the evidence",
author = "{van Genugten}, R.E. and {van Raalte}, D.H. and M. Diamant",
year = "2012",
doi = "10.1111/j.1463-1326.2011.01473.x",
language = "Undefined/Unknown",
volume = "14",
pages = "101--111",
journal = "Diabetes, Obesity and Metabolism",
issn = "1462-8902",
publisher = "Wiley-Blackwell",
number = "2",

}

Dipeptidyl peptidase-4 inhibitors and preservation of pancreatic islet-cell function: a critical appraisal of the evidence. / van Genugten, R.E.; van Raalte, D.H.; Diamant, M.

In: Diabetes, Obesity and Metabolism, Vol. 14, No. 2, 2012, p. 101-111.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Dipeptidyl peptidase-4 inhibitors and preservation of pancreatic islet-cell function: a critical appraisal of the evidence

AU - van Genugten, R.E.

AU - van Raalte, D.H.

AU - Diamant, M.

PY - 2012

Y1 - 2012

U2 - 10.1111/j.1463-1326.2011.01473.x

DO - 10.1111/j.1463-1326.2011.01473.x

M3 - Article

VL - 14

SP - 101

EP - 111

JO - Diabetes, Obesity and Metabolism

JF - Diabetes, Obesity and Metabolism

SN - 1462-8902

IS - 2

ER -